Association between supratentorial pediatric high-grade gliomas involved with the subventricular zone and decreased survival: a multi-institutional retrospective study

被引:7
|
作者
Mistry, Akshitkumar M. [1 ]
Mummareddy, Nishit [2 ]
CreveCoeur, Travis S. [3 ]
Lillard, Jock C. [4 ]
Vaughn, Brandy N. [4 ]
Gallant, Jean-Nicolas [5 ]
Hale, Andrew T. [5 ]
Griffin, Natalie [3 ]
Wellons, John C., III [1 ,6 ]
Limbrick, David D., Jr. [7 ]
Klimo, Paul, Jr. [4 ]
Naftel, Robert P. [1 ,6 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA
[2] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[3] Washington Univ, Sch Med, St Louis, MO USA
[4] Univ Tennessee, Dept Neurol Surg, Hlth Sci Ctr, Memphis, TN USA
[5] Vanderbilt Univ, Sch Med, Med Scientist Training Program, Nashville, TN 37212 USA
[6] Vanderbilt Childrens Hosp, Nashville, TN USA
[7] Washington Univ, Dept Neurosurg, St Louis, MO 63110 USA
关键词
glioblastoma; glioma; subventricular zone; survival; pediatric brain tumors; oncology; GLIOBLASTOMA STEM-CELLS; INVASION; TUMORS;
D O I
10.3171/2020.3.PEDS19593
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE The subventricular zone (SVZ), housed in the lateral walls of the lateral ventricles, is the largest neurogenic niche in the brain. In adults, high-grade gliomas in contact or involved with the SVZ are associated with decreased survival. Whether this association holds true in the pediatric population remains unexplored. To address this gap in knowledge, the authors conducted this retrospective study in a pediatric population with high-grade gliomas treated at three comprehensive centers in the United States. METHODS The authors retrospectively identified 63 patients, age 5 21 years, with supratentorial WHO grade III-IV gliomas treated at three academic centers. Basic demographic and clinical data regarding presenting signs and symptoms and common treatment variables were obtained. Preoperative MRI studies were evaluated to assess SVZ contact by tumor and to quantify tumor volume. RESULTS Sixty-three patients, including 34 males (54%), had a median age of 12.3 years (IQR 6.50-16.2) and a median tumor volume of 39.4 ml (IQR 19.4-65.8). Tumors contacting the SVZ (SVZ+) were noted in 34 patients (54%) and overall were larger than those not in contact with the SVZ (SVZ-; 51.1 vs 27.3, p = 0.002). The SVZ+ tumors were also associated with decreased survival. However, age, tumor volume, tumor grade, and treatment with chemotherapy and/or radiation were not associated with survival in the 63 patients. In the univariable analysis, near-total resection, gross-total resection, and seizure presentation were associated with increased survival (HR = 0.23, 95% CI 0.06-0.88, p = 0.03; HR = 0.26, 95% CI 0.09-0.74, p = 0.01; and HR = 0.46, 95% CI 0.22-0.97, p = 0.04, respectively). In a multivariable stepwise Cox regression analysis, only SVZ+ tumors remained significantly associated with decreased survival (HR = 1.94, 95% CI 1.03-3.64, p = 0.04). CONCLUSIONS High-grade glioma contact with the SVZ neural stem cell niche was associated with a significant decrease in survival in the pediatric population, as it is in the adult population. This result suggests that tumor contact with the SVZ is a general negative prognosticator in high-grade glioma independent of age group and invites biological investigations to understand the SVZ's role in glioma pathobiology.
引用
收藏
页码:288 / 294
页数:7
相关论文
共 50 条
  • [1] High-Grade Gliomas in Children-A Multi-Institutional Polish Study
    Napieralska, Aleksandra
    Krzywon, Aleksandra
    Mizia-Malarz, Agnieszka
    Sosna-Zielinska, Joanna
    Pawlowska, Ewa
    Krawczyk, Malgorzata A.
    Konat-Baska, Katarzyna
    Kaczorowska, Aneta
    Dabrowska, Anna
    Harat, Maciej
    CANCERS, 2021, 13 (09)
  • [2] A multi-institutional experience in pediatric high-grade glioma
    Walston, Steve
    Hamstra, Daniel A.
    Oh, Kevin
    Woods, Gary
    Guiou, Michael
    Olshefski, Randal S.
    Chakravarti, Arnab
    Williams, Terence M.
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [3] The impact of sociodemographic background on clinical presentation of high-grade gliomas: a multi-institutional retrospective analysis
    Ghosh, Sayak R.
    Lally, Anne R.
    Pecorari, Isabella L.
    Reynolds, Joshua
    Ledet, Alexander
    Begley, Sabrina
    Diaz, Elizabeth Juarez
    Zhu, Eric
    Joseph, Karan
    Mphil, Kyle McGeehan
    Schulder, Michael
    Johanns, Tanner
    Ziemba, Yonah C.
    Agarwal, Vijay
    JOURNAL OF NEURO-ONCOLOGY, 2025,
  • [4] High-grade gliomas involving the subventricular zone - a molecular study of 32 cases
    Chan, Aden Ka-yin
    Zhang, Riki Rui-qi
    Ng, Ho Keung
    BRAIN PATHOLOGY, 2019, 29 : 59 - 59
  • [5] A Multi-Institutional Polish Study of Paediatric High Grade Gliomas
    Napieralska, A.
    Krzywon, A.
    Mizia-Malarz, A.
    Sosna-Zielinska, J.
    Pawlowska, E.
    Krawczyk, M.
    Konat-Baska, K.
    Kaczorowska, A.
    Dabrowska, A.
    Harat, M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S307 - S307
  • [6] High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
    Zayac, Adam S.
    Landsburg, Daniel J.
    Hughes, Mitchell E.
    Bock, Allison M.
    Nowakowski, Grzegorz S.
    Ayers, Emily C.
    Girton, Mark
    Hu, Marie
    Beckman, Amy K.
    Li, Shaoying
    Medeiros, L. Jeffrey
    Chang, Julie E.
    Stepanovic, Adam
    Kurt, Habibe
    Sandoval-Sus, Jose
    Ansari-Lari, M. Ali
    Kothari, Shalin K.
    Kress, Anna
    Xu, Mina L.
    Torka, Pallawi
    Sundaram, Suchitra
    Smith, Stephen D.
    Naresh, Kikkeri N.
    Karimi, Yasmin H.
    Epperla, Narendranath
    Bond, David A.
    Farooq, Umar
    Saad, Mahak
    Evens, Andrew M.
    Pandya, Karan
    Naik, Seema G.
    Kamdar, Manali
    Haverkos, Bradley
    Karmali, Reem
    Oh, Timothy S.
    Vose, Julie M.
    Nutsch, Heather
    Rubinstein, Paul G.
    Chaudhry, Amina
    Olszewski, Adam J.
    BLOOD ADVANCES, 2023, 7 (21) : 6381 - 6394
  • [7] Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
    Balmaceda, Casilda
    Peereboom, David
    Pannullo, Susan
    Cheung, Ying Kuen K.
    Fisher, Paul G.
    Alavi, Jane
    Sisti, Michael
    Chen, Johnson
    Fine, Robert L.
    CANCER, 2008, 112 (05) : 1139 - 1146
  • [8] OUTCOMES IN PATIENTS WITH HIGH-GRADE MENINGIOMA (HGM): A MULTI-INSTITUTIONAL STUDY
    Mohammed, Nasser
    Patel, Chirag
    Balar, Ashish
    Van Buskirk, Samuel
    McGovern, Susan
    Raza, Shaan
    Demonte, Franco
    Ballester, Leomar
    Youssef, Michael
    Kamiya-Matsuoka, Carlos
    NEURO-ONCOLOGY, 2024, 26
  • [9] Prognostic impact of surgical treatment for high-grade neuroendocrine carcinoma of the lung: a multi-institutional retrospective study
    Haruki, Tomohiro
    Matsui, Shinji
    Oshima, Yuki
    Maeta, Hiroyuki
    Fukino, Shunsuke
    Yurugi, Yohei
    Araki, Kunio
    Umekita, Yoshihisa
    Nakamura, Hiroshige
    JOURNAL OF THORACIC DISEASE, 2022, 14 (04) : 1070 - 1078
  • [10] Prognosis of pediatric high-grade gliomas with temozolomide treatment: a retrospective, multicenter study
    Jung, Tae-Young
    Kim, Chae-Yong
    Kim, Dong-Seok
    Ra, Young-Shin
    Kim, Seong-Ho
    Baek, Hee-Jo
    Choi, Hyoung-Soo
    Kim, In-Ah
    CHILDS NERVOUS SYSTEM, 2012, 28 (07) : 1033 - 1039